Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
10/2009
10/21/2009CN100551912C Process for preparing imidapril or its intermediate
10/21/2009CN100551532C Method for preparing bisphenol catalysts and bisphenols
10/20/2009US7605271 Superhigh purity ionic liquid
10/20/2009CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection
10/20/2009CA2380986C Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions
10/15/2009WO2009126831A1 Ruthenium olefin metathesis catalysts bearing n-heterocyclic carbene ligands with substituted backbone
10/15/2009WO2009125861A1 Cysteine protease inhibitor
10/15/2009WO2008145615A3 Aminoazoline and urea derivatives for combating animal pests
10/15/2009WO2008047388A3 Improved process for the preparation of ranolazine
10/15/2009US20090259050 1,3-Diiodohydantoin compound and production method thereof
10/15/2009US20090258999 Silicon-urea-azolides, their preparation and use in the preparation of silicones with isocyanate terminal groups
10/15/2009US20090258915 Ribonucleotide reductase inhibitors and methods of use
10/15/2009US20090258901 Ligands for monoamine receptors and transporters, and methods of use thereof
10/15/2009US20090258884 Substituted amides
10/15/2009US20090258868 Heterocyclic aspartyl protease inhibitors
10/15/2009US20090258016 Substituted imidazole derivatives
10/14/2009EP1877367B1 Acetylene derivatives
10/14/2009EP1720829B1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
10/14/2009EP1397137B1 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/14/2009CN101558008A Method for purifying fluorine compound
10/14/2009CN101557810A Novel 2 -imidazoles as ligands for trace amine associated receptors (taar)
10/14/2009CN101555229A Nitro imidazole xanthogenate complex marked by TcO, preparation method and applications
10/13/2009US7601874 Antiinflammatory agents; antiarthritic agents; brain disorders; multiple sclerosis; gout; inflammatory bowel disorders; gastrointestinal disorders; psoriasis; antiallergens; autoimmune disease
10/13/2009US7601859 Organometallic complexes
10/13/2009US7601748 Anti-androgenic pyrrolidines with tumor-inhibiting action
10/13/2009US7601708 Providing sustained systemic concentrations of therapeutic or prophylactic agents such as gamma-aminobutyric acid derivatives following oral adiminstration to animals
10/13/2009US7601706 Bile-acid conjugates providing for sustained systemic concentration of drugs
10/13/2009CA2473070C Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
10/13/2009CA2429844C Mch antagonists and their use in the treatment of obesity
10/08/2009WO2009123753A1 Inhibition of bacterial biofilms with imidazole-phenyl derivatives
10/08/2009WO2009123569A1 Method for treating neurological disorders with imidazolium and imidazolinium compounds
10/08/2009WO2009122034A2 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/08/2009WO2009121535A2 Antiproliferative compounds and therapeutic uses thereof
10/08/2009US20090253914 Process for the preparation of onium salts with dialkylphosphate, dialkylphosphinate or (o-alkyl)alkyl- or alkylphosphonate anions having a low halide content
10/08/2009US20090253913 Process for the preparation of sorafenib and salts thereof
10/08/2009US20090253912 Process for the preparation of onium salts with a tetrafluoroborate anion having a reduced halide content
10/08/2009US20090253905 Process for the preparation of onium salts with alkyl- or arylsulfonate anions or alkyl- or arylcarboxylate anions having a low halide content
10/08/2009US20090253765 Angiogenesis Inhibitor Containing Amine Derivative as Active Ingredient
10/08/2009US20090253764 Use of ampk-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them
10/08/2009US20090253763 Ester compound and its use
10/08/2009US20090253656 Bcrp/abcg2 inhibitor
10/08/2009US20090253645 Methods and materials for treating and preventing inflammation of mucosal tissue
10/08/2009CA2720176A1 Antiproliferative compounds and therapeutic uses thereof
10/08/2009CA2718488A1 Novel dhsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/07/2009EP2107054A1 Antiproliferative compounds and therapeutic uses thereof
10/07/2009CN101553573A Whole-cell catalytic system comprising a hydantoinase, a racemase and a carbamoylase
10/07/2009CN101553474A Imidazolone and imidazolidinone derivatives as 11b-HSD1 inhibitors for diabetes
10/07/2009CN101550106A Industrialized preparation method of N-alkyl substituted-imidazole-5-carboxylic-acid/ester compound
10/07/2009CN101550105A Industrialized compounding method of N-alkyl substituted-5-cyanoimidazole compound
10/07/2009CN100546977C New compounds for the inhibition of rotamases and use thereof
10/06/2009US7598394 Made by reacting a cyano compound with a silylalkylisocyanide compound; silylimidazole ;
10/06/2009US7598391 Heteroaryl-ureas and their use as glucokinase activators
10/06/2009US7598389 Silylated carboxamides
10/06/2009US7598386 Sulphones which modulate the action of gamma-secretase
10/06/2009US7598242 Compounds for the treatment of inflammatory disorders
10/06/2009US7598235 Gonane ring substituted with hydroxy group and alkylamide derivatives used for achieving sustained systemic concentrations of therapeutic or prophylactic GABA(gamma-aminobutyric acid)analogs following administration to animals
10/06/2009CA2438622C Compositions containing creatine and creatinine
10/06/2009CA2301377C N-aroylphenylalanine derivatives
10/01/2009US20090247601 Peptide derivatives with therapeutic activity
10/01/2009US20090247506 Antibacterial agents
10/01/2009US20090246232 Pharmaceutical composition
09/2009
09/30/2009EP2104665A2 Imidazolone and imidazolidinone derivatives as 11b-hsd1 inhibitors for diabetes
09/30/2009CN101544606A Malononitrile compound and use thereof
09/30/2009CN100545161C Heterocyclic derivatives their preparing methods and uses
09/30/2009CN100545133C Use of composition of ionic nature as substitute reagent, composition constituting fluorination reagent and using method thereof
09/29/2009US7595344 Sulphones which modulate the action of gamma secretase
09/29/2009US7595343 Inhibitors of histone deacetylase
09/29/2009US7595332 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity
09/29/2009US7595314 Such as (2-morpholin-4-yl-5-nitro-phenyl)-[4-(5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-methanone; for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease
09/29/2009US7595162 Methods of labeling polynucleotides with energy transfer dyes
09/29/2009CA2348391C Chromenone and chromanone derivatives as integrin inhibitors
09/29/2009CA2255171C 1,3,8-triaza-spiro[4,5]decan-4-on derivatives
09/24/2009WO2009117109A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
09/24/2009WO2009116883A2 Catalytic asymetric hydrogenation
09/24/2009WO2009115651A2 N-phenyl-imidazo[1,2-a]pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof
09/24/2009WO2009115491A1 Azolin-2-ylamino compounds for combating animal pests
09/24/2009WO2009115392A1 Imidazolium salts as enzyme stabilizers
09/24/2009WO2009115391A1 Use of imidazolium salts in detergents and cleaning products
09/24/2009WO2009071050A3 METHOD FOR PRODUCING PRECURSORS FOR L-2-[18F]FLUOROPHENYLALANINE AND 6-[18F]FLUORO-L--META-TYROSINE AND THE α-METHYLATED DERIVATIVES THEREOF, PRECURSOR, AND METHOD FOR PRODUCING L-2-[18F]FLUOROPHENYLALANINE AND 6-[18F]FLUORO-L-META-TYROSINE AND THE α-METHYLATED DERIVATIVES FROM THE PRECURSOR
09/24/2009WO2008128041A3 Methods of preparing 1- (4- (1-hydroxyalkyl) -1h- imidazol-2- yl) ethanone oxime compounds
09/24/2009US20090239922 Kinesin inhibitors as cancer therapeutics
09/24/2009US20090239907 Methods and compositions for treating fish diseases
09/24/2009US20090239798 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide
09/24/2009DE102008015015A1 Hybrid material, useful e.g. to manufacture electronic components, optical components, particularly for the production of efficient catalysts, comprises solid/liquid carrier material, and thin film of ultra-pure ionic liquid
09/24/2009DE102008014760A1 Imidazolium-Salze als Enzymstabilisatoren Imidazolium salts as enzyme stabilizers
09/24/2009DE102008014759A1 Verwendung von Imidazolium-Salzen in Wasch- und Reinigungsmitteln Use of imidazolium salts in detergents and cleaning agents
09/24/2009CA2755235A1 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use
09/24/2009CA2718264A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
09/24/2009CA2716694A1 Process
09/24/2009CA2710811A1 N-phenyl-imidazo[1,2-a]pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof
09/23/2009EP2103600A1 Clathrate compound, curing catalyst, composition for forming cured resin, and cured resin
09/23/2009EP2102353A2 Whole-cell catalytic system comprising a hydantoinase, a racemase and a carbamoylase
09/23/2009EP2102154A1 Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
09/23/2009EP2101762A1 Novel 2 -imidazoles as ligands for trace amine associated receptors (taar)
09/23/2009EP1467989B1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection
09/23/2009EP0946508B1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS
09/23/2009CN101541759A Substituted dihydroimidazoles and their use in the treatment of tumors
09/23/2009CN101538718A Carbon steel restrainer and use method thereof
09/23/2009CN101538284A Preparation method and application of 99Tcm-EDTA-MTI coordination compound
09/23/2009CN101538244A 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 345